Follow RSS for latest reports on this topicBioPharmaceuticals - Market Research and Reports

Transposagen Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 14-12-2018]

SummaryTransposagen Biopharmaceuticals Inc (Transposagen) is a biotechnology company that offers range of gene editing technologies and services that address the research needs of academic and drug discovery investigators. The company offers cell and animal model gene editing, off-the-shelf products and custom reagents. It provides cell engineering, rodent model engineering, gene editing reagents ...Read More >>>

Published:
2018-12-14

Published by: Global Data

Prices Starting From:
$250

SK Biopharmaceuticals Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 06-12-2018]

SummarySK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R, SKL-PSY and FZ-016; SKL-ADHD and carisbamate drugs, among others. SK Biopharmaceuticals offers rese...Read More >>>

Published:
2018-12-06

Published by: Global Data

Prices Starting From:
$250

Paradigm Biopharmaceuticals Ltd (PAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

SummaryParadigm Biopharmaceuticals Ltd (Paradigm Biopharma) is a biopharmaceutical company. The company focused on research and development of therapeutic products for human use. It offers pentosan polysulphate sodium (PPS) drugs for new orthopaedic and respiratory applications. Paradigm Biopharma offers drugs in the injectable and tablet forms for bone marrow edema, respiratory disease, alphavira...Read More >>>

Published:
2018-11-08

Published by: Global Data

Prices Starting From:
$250

Sienna Biopharmaceuticals Inc (SNNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018]

SummarySienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a clinical-stage biopharmaceutical company that develops and commercializes topical products in medical dermatology and aesthetics. Through its topical photoparticle therapy platform, the company advanced its product SNA-001, into pivotal clinical trials for both acne vulgaris and the reduction of unwanted light-pigmented hair. SN...Read More >>>

Published:
2018-10-23

Published by: Global Data

Prices Starting From:
$250

Eiger BioPharmaceuticals Inc (EIGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 23-10-2018]

SummaryEiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are in Phase 2 trials used for the treatment of hepatitis delta virusinfection; Exendin 9-39, a phase 2 ...Read More >>>

Published:
2018-10-23

Published by: Global Data

Prices Starting From:
$250

Navidea Biopharmaceuticals Inc (NAVB) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

SummaryNavidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi’s, NAS, Cardiovascular diseases, Sentin...Read More >>>

Published:
2018-10-16

Published by: Global Data

Prices Starting From:
$250

Provectus Biopharmaceuticals Inc (PVCT) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

SummaryProvectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated x...Read More >>>

Published:
2018-10-16

Published by: Global Data

Prices Starting From:
$250

Navidea Biopharmaceuticals Inc (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

SummaryNavidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi’s, NAS, Cardiovascular diseases, Sentin...Read More >>>

Published:
2018-10-12

Published by: Global Data

Prices Starting From:
$250

XTL Biopharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

SummaryXTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin. Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus. XTL’s recombinant ...Read More >>>

Published:
2018-10-12

Published by: Global Data

Prices Starting From:
$250

RegeneRx Biopharmaceuticals Inc (RGRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

SummaryRegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its business development services include clinical development and commercialization interests in desired pharm...Read More >>>

Published:
2018-10-12

Published by: Global Data

Prices Starting From:
$250

Provectus Biopharmaceuticals Inc (PVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

SummaryProvectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated x...Read More >>>

Published:
2018-10-12

Published by: Global Data

Prices Starting From:
$250

Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review [Report Updated: 18-09-2018]

Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.This up-to-the-minute company report will help you to formulate strategies to dr...Read More >>>

Published:
2018-09-18

Published by: Global Data

Prices Starting From:
$125

Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review [Report Updated: 18-09-2018]

Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strate...Read More >>>

Published:
2018-09-18

Published by: Global Data

Prices Starting From:
$125

Samyang Biopharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 17-09-2018]

SummarySamyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, synthetic absorbable suture materials, biodegradable dental implant (GTR, GBR) membrane and partially ...Read More >>>

Published:
2018-09-17

Published by: Global Data

Prices Starting From:
$250

Global RNA-based Biopharmaceuticals Market Status and Outlook 2018-2025 [Report Updated: 12-08-2018]

Report SnapshotKey Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)Part 1:Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market OverviewPart 2:Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flo...Read More >>>

Published:
2018-08-12

Published by: 99Strategy

Prices Starting From:
$4000

NGM Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

SummaryNGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM313, NGM217 and NGM120. Its NGM313 is an agonistic antibody of the beta-klotho pathway and developm...Read More >>>

Published:
2018-07-24

Published by: Global Data

Prices Starting From:
$250

Oxeia Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 10-05-2018]

SummaryOxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops therapies for the treatment of mild traumatic brain injury or concussions and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, a mitochondrial stabilizer by crossing the blood brain barrier to restore normal mitochondrial activity. It con...Read More >>>

Published:
2018-05-10

Published by: Global Data

Prices Starting From:
$250

Adgero Biopharmaceuticals Holdings Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-04-2018]

SummaryAdgero Biopharmaceuticals Holdings Inc (Adgero) is a biopharmaceutical company which advances its proprietary late stage photodynamic therapy (PDT) for the treatment of unmet clinical needs of patients with cutaneous metastatic breast cancer (CMBC) and bile duct cancer. Its PDT is a treatment utilizes light sensitive compounds which act as catalyst to produce a form of oxygen that induces l...Read More >>>

Published:
2018-04-12

Published by: Global Data

Prices Starting From:
$250

XTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

SummaryXTL Biopharmaceuticals Ltd (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and late-stage pharmaceutical product candidates for the treatment of medical needs. The company’s pipeline products comprise hCDR1 peptide and recombinant erythropoietin (rHuEPO). Its hCDR1 peptide is used for the treatment of systemic lupu...Read More >>>

Published:
2018-03-09

Published by: Global Data

Prices Starting From:
$300

RegeneRx Biopharmaceuticals Inc (RGRX) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

SummaryRegeneRx Biopharmaceuticals Inc (RegeneRx) is a biopharmaceutical company that provides clinical stage drug development solutions. The company offers clinical trials, science and discovery and business development services. Its business development services include clinical development and commercialization interests in desired pharmaceutical therapeutic fields for suitable infrastructure, ...Read More >>>

Published:
2018-03-09

Published by: Global Data

Prices Starting From:
$300

Eiger BioPharmaceuticals Inc (EIGR) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

SummaryEiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp, is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company’s pipeline products comprise Lonafarnib and Lambda, which are in Phase 2 trials used for the treatment of hepatitis delta virusinfection; Exendin 9-39, a phase 2 pro...Read More >>>

Published:
2018-03-09

Published by: Global Data

Prices Starting From:
$300

3P Biopharmaceuticals SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 20-12-2017]

Summary3P Biopharmaceuticals SL (3P), a subsidiary of Infarco SA is a biotechnology company that offers biological and cell therapy products. The company offers biologic services such as cell-banks, process development, GMP manufacturing and analytical QC services. Its cell therapy services comprise GMP manufacturing, development services, project management, research and development, quality assu...Read More >>>

Published:
2017-12-20

Published by: Global Data

Prices Starting From:
$250

Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review [Report Updated: 13-11-2017]

SummaryAlder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection system and novel mab xpress antibody production system. Its pipeline products include clazakizumab an...Read More >>>

Published:
2017-11-13

Published by: Global Data

Prices Starting From:
$300

Innovate Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-08-2017]

SummaryInnovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase II for inflammatory bowel disorders, mild to moderate ulcerative colitis. Its MRCP is a clinical im...Read More >>>

Published:
2017-08-24

Published by: Global Data

Prices Starting From:
$250

Sienna Biopharmaceuticals Inc - Medical Equipment - Deals and Alliances Profile [Report Updated: 11-08-2017]

SummarySienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle therapy (PPT) platform for treating acne, pigmentation and unwanted hair growth. The company’s pipeli...Read More >>>

Published:
2017-08-11

Published by: Global Data

Prices Starting From:
$250

3P Biopharmaceuticals SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017]

Summary3P Biopharmaceuticals SL (3P), a subsidiary of Infarco SA is a biotechnology company that offers biological and cell therapy products. The company offers biologic services such as cell-banks, process development, GMP manufacturing and analytical QC services. Its cell therapy services comprise GMP manufacturing, development services, project management, research and development, quality assu...Read More >>>

Published:
2017-07-20

Published by: Global Data

Prices Starting From:
$250

Navidea Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report [Report Updated: 12-06-2017]

Navidea Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline's Navidea Biopharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and p...Read More >>>

Published:
2017-06-12

Published by: Marketline

Prices Starting From:
$350

XTL Biopharmaceuticals Ltd (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 18-05-2017]

SummaryXTL Biopharmaceuticals Ltd (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline products comprise hCDR1 peptide and recombinant erythropoietin (rHuEPO). Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus (SLE); and rHuEPO is a compound developed to prolon...Read More >>>

Published:
2017-05-18

Published by: Global Data

Prices Starting From:
$250

Genervon Biopharmaceuticals LLC - Product Pipeline Review - 2016 [Report Updated: 30-12-2016]

Genervon Biopharmaceuticals LLC - Product Pipeline Review - 2016SummaryGlobal Markets Direct’s, ‘Genervon Biopharmaceuticals LLC - Product Pipeline Review - 2016’, provides an overview of the Genervon Biopharmaceuticals LLC’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Genervon Biopharmaceuticals LLC,...Read More >>>

Published:
2016-12-30

Published by: Global Markets Direct

Prices Starting From:
$1500

Gallus BioPharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryGallus BioPharmaceuticals LLC (Gallus), a subsidiary of DPx Holdings BV is a biopharmaceutical company that provides contract manufacturing services. The company’s services include protein expertise, process development, process validation, analytical method development, regulatory compliance, cell banking and storage, aseptic filling and program management services, among others. It owns...Read More >>>

Published:
2016-11-29

Published by: Global Data

Prices Starting From:
$250

Cantab Biopharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryCantab Biopharmaceuticals Ltd (CBL), subsidiary of Celtic Pharma Holdings LP is a biopharmaceutical company that discovers and develops a range of drugs and drug formulations for the healthcare industry. The company’s activities include biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical develo...Read More >>>

Published:
2016-11-24

Published by: Global Data

Prices Starting From:
$250

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline products comprise hCDR1 peptide and recombinant erythropoietin (rHuEPO). Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus (SLE); and rHuEPO is a compound developed to prolo...Read More >>>

Published:
2016-07-11

Published by: Global Data

Prices Starting From:
$300

Transposagen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryTransposagen Biopharmaceuticals, Inc. (Transposagen) is a biotechnology company that provides animal models, cell lines, stem cells and research tools and technologies for drug discovery and development research. The company’s gene modification tools include Footprint-Free Gene Editing, XTN TALENs, Stem Cell Engineering Services, Crispr/Cas Gene Modification, Custom Engineered Rodents, Ce...Read More >>>

Published:
2016-05-13

Published by: Global Data

Prices Starting From:
$250

XTL Biopharmaceuticals Ltd. (XTLB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline products comprise hCDR1 peptide and recombinant erythropoietin (rHuEPO). Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus (SLE); and rHuEPO is a compound developed to prolo...Read More >>>

Published:
2016-05-13

Published by: Global Data

Prices Starting From:
$250

NGM Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryNGM Biopharmaceuticals, Inc. (NGM Bio) is a clinical stage biopharmaceutical company that focuses on the development of drug discovery platform to generate biologic drug candidates to treat cardio-metabolic and liver diseases. The company’s product pipeline includes NGM282, NGM386 and NGM395, NGM313. Its products are used for the treatment of various metabolic diseases such as type 2 diab...Read More >>>

Published:
2016-05-10

Published by: Global Data

Prices Starting From:
$250

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummarySK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals), a subsidiary of SK Holdings Co., Ltd. is a pharmaceutical company that develops and markets innovative drugs for the treatment of central nervous system. The company offers plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R, SKL-PSY and FZ-016; SKL-ADHD and carisbamate drugs. It provides research and development; biol...Read More >>>

Published:
2016-05-10

Published by: Global Data

Prices Starting From:
$250

Gallus BioPharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryGallus BioPharmaceuticals, LLC (Gallus), a subsidiary of DPx Holdings B.V. is a biopharmaceutical company that provides contract manufacturing services. The company’s services include protein expertise, process development, process validation, analytical method development, regulatory compliance, cell banking and storage, aseptic filling and program management services, among others. It o...Read More >>>

Published:
2016-05-06

Published by: Global Data

Prices Starting From:
$250

Innovate Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryInnovate Biopharmaceuticals, Inc. (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase II for inflammatory bowel disorders, mild to moderate ulcerative colitis. Its MRCP is a clinical imaging m...Read More >>>

Published:
2016-04-27

Published by: Global Data

Prices Starting From:
$250

XTL Biopharmaceuticals, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.MarketLines' XTL Biopharmaceuticals, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description...Read More >>>

Published:
2016-04-15

Published by: Marketline

Prices Starting From:
$350

Eiger BioPharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SummaryEiger BioPharmaceuticals, Inc. (Eiger) is a biopharmaceutical company that discovers and develops new antiviral agents to treat hepatitis virus infection. The company’s product candidates include EBP921, EBP922, Lonafarnib and Tipifarnib. Its HDV large delta antigen protein (HDAgs) contains a nucleocapsid-like structure with the genomec. These genomec are enclosed by a lipid envelope, whi...Read More >>>

Published:
2016-03-10

Published by: Global Data

Prices Starting From:
$250